Goldman Sachs Group Inc Sc Pharmaceuticals Inc. Call Options Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SCPH
# of Institutions
96Shares Held
37.1MCall Options Held
110KPut Options Held
12.1K-
Orbimed Advisors LLC San Diego, CA6.06MShares$21.8 Million0.65% of portfolio
-
Rubric Capital Management LP New York, NY4.78MShares$17.2 Million0.61% of portfolio
-
Aigh Capital Management LLC Baltimore, MD4.12MShares$14.8 Million7.6% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX2.23MShares$8.01 Million0.04% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.05MShares$7.38 Million0.37% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $98.6M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...